{
    "medicine_id": "916ede5c9b0e60f1da88e1450fe4d25fc3756d90",
    "platform_id": "DB00049",
    "metadata": {
        "name": "Elitek 1 5 mg ml Injection powder for solution",
        "composition": "1 5 mg ml Rasburicase",
        "clinical_particulars": {
            "therapeutic_indications": "For treatment of hyperuricemia reduces elevated plasma uric acid levels from chemotherapy",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Drugs used to treat lympohoid leukemia non Hodgkin s lymphoma and acute myelogenous leukemia often lead to the accumulation of toxic plasma levels of purine metabolites i e uric acid The injection of rasburicase reduces levels of uric acid and mitigates the toxic effects of chemotherapy induced tumor lysis",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB00232",
                        "description": "The therapeutic efficacy of Rasburicase can be decreased when used in combination with Methyclothiazide"
                    },
                    {
                        "drugbank-id": "DB00436",
                        "description": "The therapeutic efficacy of Rasburicase can be decreased when used in combination with Bendroflumethiazide"
                    },
                    {
                        "drugbank-id": "DB00562",
                        "description": "The therapeutic efficacy of Rasburicase can be decreased when used in combination with Benzthiazide"
                    },
                    {
                        "drugbank-id": "DB00606",
                        "description": "The therapeutic efficacy of Rasburicase can be decreased when used in combination with Cyclothiazide"
                    },
                    {
                        "drugbank-id": "DB00774",
                        "description": "The therapeutic efficacy of Rasburicase can be decreased when used in combination with Hydroflumethiazide"
                    },
                    {
                        "drugbank-id": "DB00880",
                        "description": "The therapeutic efficacy of Rasburicase can be decreased when used in combination with Chlorothiazide"
                    },
                    {
                        "drugbank-id": "DB00999",
                        "description": "The therapeutic efficacy of Rasburicase can be decreased when used in combination with Hydrochlorothiazide"
                    },
                    {
                        "drugbank-id": "DB01021",
                        "description": "The therapeutic efficacy of Rasburicase can be decreased when used in combination with Trichlormethiazide"
                    },
                    {
                        "drugbank-id": "DB01324",
                        "description": "The therapeutic efficacy of Rasburicase can be decreased when used in combination with Polythiazide"
                    },
                    {
                        "drugbank-id": "DB13430",
                        "description": "The therapeutic efficacy of Rasburicase can be decreased when used in combination with Mebutizide"
                    },
                    {
                        "drugbank-id": "DB13532",
                        "description": "The therapeutic efficacy of Rasburicase can be decreased when used in combination with Cyclopenthiazide"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}